Literature DB >> 28118021

Notification of Nontuberculous Mycobacteria: An Australian Perspective.

Rachel Thomson1,2,3, Ellen Donnan4, Anastasios Konstantinos5.   

Abstract

In Queensland, Australia, all cases of mycobacterial infection (tuberculosis [TB] and nontuberculous mycobacteria [NTM]) are notifiable under the Queensland Public Health Act (2005). This process originally emerged to avoid NTM confounding with notification of cases of TB, but has facilitated awareness of the increasing incidence and changing epidemiology of NTM. Although initially not a public health priority, the notification process has facilitated research that has led to an appreciation of both public health and environmental health issues associated with these pathogens. When reports of NTM infections were low in frequency, reporting was managed largely by clinicians specializing in TB. However, as reports of NTM isolates surpassed those for TB, the workload associated with clinical reporting exceeded resources. The Communicable Diseases Branch transitioned to digital reporting of laboratory isolates of mycobacteria, thereby enabling weekly and quarterly reporting of data, and generation of more detailed annual reports. The reports now include species and geographic distributions by health service district, allowing identification of clusters requiring further investigation and systematic reviews of different species. With ecological and climate change, the distribution and virulence of these emerging pathogens are evolving. Evidence of transmission of highly virulent and antibiotic-resistant clones of Mycobacterium abscessus among patients with cystic fibrosis internationally heightens the need for timely reporting to public health authorities. Ongoing systematic monitoring by public health authorities will be crucial to our understanding of NTM diseases.

Entities:  

Keywords:  Mycobacterium abscessus; Mycobacterium avium complex; mycobacteria; nontuberculous mycobacteria; public health

Mesh:

Year:  2017        PMID: 28118021     DOI: 10.1513/AnnalsATS.201612-994OI

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  6 in total

1.  Clinically refined epidemiology of nontuberculous mycobacterial pulmonary disease in South Korea: overestimation when relying only on diagnostic codes.

Authors:  Jae Hyeon Park; Sue Shin; Taek Soo Kim; Hyunwoong Park
Journal:  BMC Pulm Med       Date:  2022-05-13       Impact factor: 3.320

2.  The first Saudi Arabian national inventory study revealed the upcoming challenges of highly diverse non-tuberculous mycobacterial diseases.

Authors:  Bright Varghese; Mushira Enani; Mohammed Shoukri; Sameera AlJohani; Hawra Al Ghafli; Sahar AlThawadi; Sahal Al Hajoj
Journal:  PLoS Negl Trop Dis       Date:  2018-05-25

3.  Anomalies in T Cell Function Are Associated With Individuals at Risk of Mycobacterium abscessus Complex Infection.

Authors:  Viviana P Lutzky; Champa N Ratnatunga; Daniel J Smith; Andreas Kupz; Denise L Doolan; David W Reid; Rachel M Thomson; Scott C Bell; John J Miles
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

4.  Increasing Non-tuberculous Mycobacteria Infections in Veterans With COPD and Association With Increased Risk of Mortality.

Authors:  Fahim F Pyarali; Michael Schweitzer; Valeria Bagley; Oriana Salamo; Andrea Guerrero; Arash Sharifi; Michael Campos; Andrew Quartin; Mehdi Mirsaeidi
Journal:  Front Med (Lausanne)       Date:  2018-11-06

Review 5.  Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches.

Authors:  Jennifer R Honda; Ravleen Virdi; Edward D Chan
Journal:  Front Microbiol       Date:  2018-08-30       Impact factor: 5.640

Review 6.  The Rise of Non-Tuberculosis Mycobacterial Lung Disease.

Authors:  Champa N Ratnatunga; Viviana P Lutzky; Andreas Kupz; Denise L Doolan; David W Reid; Matthew Field; Scott C Bell; Rachel M Thomson; John J Miles
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.